1. Zacks.com issued a new target of $5.30 with an upper band of $10
2. The two downgrades that came in, one change from mkt outperform to mkt perform and the other from buy to hold.
3. It hit a low of 4.75 on Friday and then a new low $4.60 yesterday and bounced back to a little over $5.
4. My prediction is that it would touch $6 by next week or so for two reasons. First OMER has only 18.2 million shares a float, so it can be moved very easily and especially if some big daddy are interested in its long term prospects. Secondly many people must have shorted this stock, and soon with no movement south they will start covering. Personally at this price it has very low risk to go down and its not like the FDA hasn't approved the drug or something. People who understand that its a short term glitch and OMER still has a lot to offer will understand what I mean.